Literature DB >> 12934790

Sustained-release niacin for prevention of migraine headache.

David A Velling1, David W Dodick, Jesse J Muir.   

Abstract

Considerable advances in the diagnosis and treatment of migraine headache have occurred during the past decade, but treatment options for acute migraine attacks have expanded at a faster rate than those for prophylaxis. We describe a patient whose migraine headaches responded dramatically to sustained-release niacin as preventive treatment. Niacin is not generally considered to be effective for migraine prevention. However, low plasma levels of serotonin have been implicated in migraine pathogenesis, and niacin may act as a negative feedback regulator on the kynurenine pathway to shunt tryptophan into the serotonin pathway, thus increasing plasma serotonin levels. Sustained-release niacin merits further study as a potentially useful preventive therapy for migraine headache.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934790     DOI: 10.4065/78.6.770

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

Review 1.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

Review 2.  Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility.

Authors:  Jonathan M Borkum
Journal:  Neurochem Res       Date:  2021-04-30       Impact factor: 3.996

Review 3.  The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature.

Authors:  Jonathan Prousky; Dugald Seely
Journal:  Nutr J       Date:  2005-01-26       Impact factor: 3.271

4.  Hyperlipidemia in migraine: Is it more frequent in migraineurs?

Authors:  Alia Saberi; Hamid Reza Hatamian; Ehsan Kazemnejad; Nasim Ghorbannejad
Journal:  Iran J Neurol       Date:  2011

5.  The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.

Authors:  Bertrand Lebouché; Mohammad-Ali Jenabian; Joel Singer; Gina M Graziani; Kim Engler; Benoit Trottier; Réjean Thomas; Marie-Josée Brouillette; Jean-Pierre Routy
Journal:  Trials       Date:  2014-10-07       Impact factor: 2.279

6.  Association between Dietary Niacin Intake and Migraine among American Adults: National Health and Nutrition Examination Survey.

Authors:  Huanxian Liu; Lu Wang; Chunfu Chen; Zhao Dong; Shengyuan Yu
Journal:  Nutrients       Date:  2022-07-25       Impact factor: 6.706

7.  Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period.

Authors:  Bernadett Tuka; Aliz Nyári; Edina Katalin Cseh; Tamás Körtési; Dániel Veréb; Ferenc Tömösi; Gábor Kecskeméti; Tamás Janáky; János Tajti; László Vécsei
Journal:  J Headache Pain       Date:  2021-06-25       Impact factor: 7.277

Review 8.  Nutrients to Improve Mitochondrial Function to Reduce Brain Energy Deficit and Oxidative Stress in Migraine.

Authors:  Michal Fila; Cezary Chojnacki; Jan Chojnacki; Janusz Blasiak
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.